Received Oct 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 7FY52 | — |
dizziness; ringing in the ears; still does not feel comfortable driving; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of dizziness in a 40-year-old male patient who received Flu Seasonal TIV Quebec (FluLaval 2025-2026 season) (batch number 7FY52, expiry date 30-JUN-2026) for prophylaxis. On 01-OCT-2025, the patient received FluLaval 2025-2026 season. In OCT-2025, less than a week after receiving FluLaval 2025-2026 season, the patient experienced dizziness (Verbatim: dizziness), ringing in ears (Verbatim: ringing in the ears) and discomfort (Verbatim: still does not feel comfortable driving). The outcome of the dizziness and ringing in ears were unknown and the outcome of the discomfort was not resolved. It was unknown if the reporter considered the dizziness, ringing in ears and discomfort to be related to FluLaval 2025-2026 season and Flulaval Pre-Filled Syringe Device. It was unknown if the company considered the dizziness, ringing in ears and discomfort to be related to FluLaval 2025-2026 season and Flulaval Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 02-OCT-2025 A patient experienced dizziness and ringing in the ears after receiving the Flulaval vaccine. The nurse who administered the vaccine submitted a report to VAERS but wondered if they should have been concerned. The reporter stated this was an employee, and they had upcoming employee vaccine clinics. This employee (patient) still did not feel comfortable driving.